Cambodia stops important tenofovir prevention trial.
A study that could open the door to pharmacological HIV prevention until a vaccine is available was stopped in Cambodia, after sex workers objected to lack of health insurance after the trial.
James
John S
JS
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D002160:Cambodia; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000068698:Tenofovir
D063065:Organophosphonates; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine